In June 2009 the American Diabetes Association (ADA), International Diabetes Federation (IDF), and European Association for the Study Of Diabetes (EASD) began recommending diabetes A1C diagnosis testing. While the A1C for diagnosis of diabetes is not the only test that should be administered by doctors, the committee’s recommendation reflects the A1C test’s ability to provide a different perspective on blood glucose management and average levels. This is because A1C values vary less than fasting plasma glucose (FPG) as patients do not need to fast and A1C values have also been correlated with the risk of developing retinopathy. The downside of the A1C test is its price; it is more expensive than other tests. The ADA noted that the price is prohibitive, particularly in the developing world. Additionally, A1C is inaccurate in cases of severely low hemoglobin levels caused by chronic anemia, hemolytic anemia, and other forms, which are prevalent in …